.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Chubb
Baxter
Healthtrust
Julphar
Cipla
Boehringer Ingelheim
McKesson
Cantor Fitzgerald
Citi

Generated: July 25, 2017

DrugPatentWatch Database Preview

ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL Drug Profile

« Back to Dashboard

Which patents cover Erythromycin Ethylsuccinate And Sulfisoxazole Acetyl, and when can generic versions of Erythromycin Ethylsuccinate And Sulfisoxazole Acetyl launch?

Erythromycin Ethylsuccinate And Sulfisoxazole Acetyl is a drug marketed by Barr and is included in one NDA.

The generic ingredient in ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL is erythromycin ethylsuccinate; sulfisoxazole acetyl. There are ninety-eight drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the erythromycin ethylsuccinate; sulfisoxazole acetyl profile page.

Summary for Tradename: ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list2
Clinical Trials: see list104,947
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL at DailyMed

Pharmacology for Tradename: ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Barr
ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL
erythromycin ethylsuccinate; sulfisoxazole acetyl
GRANULE;ORAL062759-001May 20, 1988RXNoYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Cipla
Harvard Business School
UBS
Moodys
AstraZeneca
Daiichi Sankyo
Mallinckrodt
US Army
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot